...
首页> 外文期刊>Human Genetics >Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals.
【24h】

Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals.

机译:从正常个体获得的外周血细胞中,端粒长度和端粒酶活性随年龄而变化。

获取原文
获取原文并翻译 | 示例
           

摘要

The telomerase activity and length of telomeres of peripheral blood mononuclear cells obtained from 124 healthy individuals aged 4-95 years was measured. Telomerase activity level was semiquantitatively assessed by a fluorescent-telomeric repeat amplification protocol (fluorescent-TRAP) using an internal telomerase assay standard, fluorescent primers and an automated laser fluorescent DNA sequencer. Telomeric length, measured by assay of terminal restriction fragments (TRFs), was determined in HinfI-digested DNA by Southern blot analysis using a (TTAGGG)4 probe. TRF length was determined in 80 individuals and age-related progressive reduction of size was observed. TRF length in peripheral blood mononuclear cells obtained from normal individuals (aged 4-39 years) decreased by approximately 84 bp per year, while in individuals aged > or = 40 years it decreased by 41 bp per year. In contrast, telomerase activity showed an apparent biphasic pattern with aging. Individuals aged 4-39 years showed a progressive decrease in telomerase activity, whereas 65% of those aged > or = 40 years showed relatively stable but very low telomerase activity, and the remaining individuals aged > or = 40 years had no detectable telomerase activity. These data obtained from normal individuals might in the future be of value to help risk stratify and manage the care of patients with leukemia.
机译:测量了从124名年龄在4-95岁的健康个体获得的外周血单核细胞的端粒酶活性和端粒长度。使用内部端粒酶测定标准品,荧光引物和自动激光荧光DNA测序仪,通过荧光端粒重复扩增方案(fluorescent-TRAP)对端粒酶活性水平进行半定量评估。通过检测末端限制性片段(TRF)来测定端粒长度,方法是使用(TTAGGG)4探针通过Southern blot分析在HinfI消化的DNA中进行测定。确定了80位个体的TRF长度,并观察到了年龄相关的大小逐渐减少。从正常个体(4-39岁)获得的外周血单核细胞中的TRF长度每年减少约84 bp,而年龄大于或等于40岁的个体的TRF长度每年减少41 bp。相比之下,端粒酶活性随衰老表现出明显的两相模式。 4-39岁的个体显示端粒酶活性逐渐降低,而≥40岁的个体中有65%表现出相对稳定但端粒酶活性非常低,而≥40岁的其余个体则没有可检测的端粒酶活性。从正常人那里获得的这些数据在将来可能有助于将风险分层并管理白血病患者的护理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号